MED
CEO
2026-01-05–present
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Nicholas Johnson is recorded as CEO at Medifast Inc (MED). Medifast Inc reported in an 8-K filed May 26, 2026 that Nicholas Johnson was appointed Chief Executive Officer, effective June 1, 2026. Medifast Inc reported in an 8-K filed January 5, 2026 that Nicholas Johnson was appointed President of Medifast. Medifast Inc reported in an 8-K filed January 5, 2026 that Nicholas Johnson was appointed President of Medifast, effective January 5, 2026. Nicholas Johnson has spoken on 1 earnings call across 1 company, most recently for Medifast Inc on August 3, 2026.
“On May 20, 2026, the Board appointed Nicholas Johnson, age 46, to serve as Chief Executive Officer of the Company, effective June 1, 2026.”
“The Board has appointed Medifast’s Chief Field Operations Officer Nicholas Johnson as President of Medifast, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-06-01–present
SEC 8-K
2026-01-05–present
Recorded roles and call appearances connecting this person to public companies.
MED
CEO
2026-01-05–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.